Paris—Creapharm group acquired a majority stake in LinBox, a French private biobank specialized in cryopreservation.

The market for innovative therapies is booming. The conservation and highly-secured storage of these products, as well as their logistics, is today a real challenge for pharmaceutical laboratories, biotechnology companies and research centers.

By choosing to join forces with a leader in biobanking, LinBox, an experienced player with complementary know-how, Creapharm group has created a new business unit around Creapharm Bioservices, the first private biobank offering cryogenic storage of biological products used for therapeutic purposes.

Creapharm group was advised by Dentons with a team led by Jean-Marc Grosperrin, M&A partner, Romain Picard and Coralie Leger, associates. Other practices including Company Law (Thierry Renaud de la Faverie, partner), IP&T (Loïc Lemercier, partner and Tom Blanchet, associate), Labor Law (Katell Déniel-Allioux, partner and Nathaly Blin, of counsel), Data Privacy (Christophe Fichet, partner and Maxime d'Angelo Petrucci, associate), and Real Estate (Maxime Simonnet, partner and Charlotte Rossi, associate) were also involved.

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com